NuVasive

$68.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+0.12%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell NuVasive and other stocks, options, and ETFs commission-free!

About NUVA

NuVasive, Inc. engages in the development, manufacture, sale, and provision of procedural solutions for spine surgery. It offers a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring.

CEO

J. Christopher Barry

Employees

2,700

Headquarters

San Diego, California

Founded

1997

Market Cap

3.48B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

586.82K

High Today

$69.50

Low Today

$68.29

Open Price

$68.52

Volume

545.94K

52 Week High

$69.50

52 Week Low

$43.11

Analyst Ratings

44%

of 18 ratings

Buy

44%

Hold

44%

Sell

11%

NUVA Earnings

-$0.52

-$0.10

$0.31

$0.73

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 5, After Hours